Management of hormone-refractory prostate cancer

被引：0
|
作者：
Dogliotti, L [1 ]
Mosca, A [1 ]
机构：
[1] Univ Turin, Dept Sci Clin & Biol, Azienda Osped San Luigi, Turin, Italy
来源：
TUMORI | 2003年
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S147 / S149
页数：3
相关论文
共 50 条
  • [1] Octreotide in the management of hormone-refractory prostate cancer
    Vainas, IG
    [J]. CHEMOTHERAPY, 2001, 47 : 109 - 126
  • [2] Revolutions in the management of hormone-refractory prostate cancer
    Abrahamsson, PA
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2003, 2 (03) : 1 - 2
  • [3] Hormone-Refractory prostate cancer
    Rini B.I.
    Small E.J.
    [J]. Current Treatment Options in Oncology, 2002, 3 (5) : 437 - 446
  • [4] Update in the management of patients with hormone-refractory prostate cancer
    Moore, CN
    George, DJ
    [J]. CURRENT OPINION IN UROLOGY, 2005, 15 (03) : 157 - 162
  • [5] The role of urologists in the management of hormone-refractory prostate cancer
    Pummer, K
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2002, 1 (02) : 24 - 28
  • [6] Taxanes in hormone-refractory prostate cancer
    Kang, MH
    Figg, WD
    Dahut, W
    [J]. CANCER PRACTICE, 1999, 7 (05) : 270 - 272
  • [7] Chemotherapy of the hormone-refractory prostate cancer
    Heine, K
    Wolff, JM
    [J]. AKTUELLE UROLOGIE, 2004, 35 (03) : 209 - 214
  • [8] Therapy of hormone-refractory prostate cancer
    Heidenreich, A
    [J]. UROLOGE, 2005, 44 (12): : 1481 - 1494
  • [9] Looking to the future: Advances in the management of hormone-refractory prostate cancer
    Trachtenberg, J
    Blackledge, G
    [J]. EUROPEAN UROLOGY SUPPLEMENTS, 2002, 1 (07) : 44 - 53
  • [10] ORAL CYCLOPHOSPHAMIDE FOR THE MANAGEMENT OF HORMONE-REFRACTORY PROSTATE-CANCER
    RAGHAVAN, D
    COX, K
    PEARSON, BS
    COOREY, GJ
    ROGERS, J
    WATT, WH
    COATES, AS
    MCNEIL, E
    GRYGIEL, JJ
    [J]. BRITISH JOURNAL OF UROLOGY, 1993, 72 (05): : 625 - 628
12345